ProAssurance Corporation (NYSE:PRA – Get Free Report) has earned a consensus recommendation of “Hold” from the seven brokerages that are covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a strong buy rating to the company. The average 1-year price target among brokers that have covered the stock in the last year is $21.50.
A number of equities analysts have weighed in on the company. Weiss Ratings reissued a “hold (c)” rating on shares of ProAssurance in a research note on Saturday. Zacks Research raised ProAssurance from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 22nd.
Check Out Our Latest Report on ProAssurance
Hedge Funds Weigh In On ProAssurance
ProAssurance Stock Performance
NYSE PRA opened at $24.11 on Friday. The stock’s fifty day moving average is $23.91 and its two-hundred day moving average is $23.53. The firm has a market capitalization of $1.24 billion, a P/E ratio of 25.64 and a beta of 0.12. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.26 and a current ratio of 0.26. ProAssurance has a fifty-two week low of $13.00 and a fifty-two week high of $24.22.
ProAssurance (NYSE:PRA – Get Free Report) last released its quarterly earnings data on Friday, May 20th. The insurance provider reported $0.04 earnings per share for the quarter. The company had revenue of $220.02 million for the quarter. ProAssurance had a return on equity of 5.62% and a net margin of 4.33%. On average, research analysts anticipate that ProAssurance will post 0.8 earnings per share for the current year.
ProAssurance Company Profile
ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.
Featured Stories
- Five stocks we like better than ProAssurance
- Profitably Trade Stocks at 52-Week Highs
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- What is a buyback in stocks? A comprehensive guide for investors
- Is Landstar the Next Big Winner in Transportation Stocks?
Receive News & Ratings for ProAssurance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProAssurance and related companies with MarketBeat.com's FREE daily email newsletter.
